Somatostatin analogues remain most effective for dumping syndrome with emerging GLP-1 and glucagon therapies under evaluation | Research

The takeaway

Dumping syndrome management follows an incremental approach: dietary modification → acarbose/viscosity enhancers → somatostatin analogues (most effective), with GLP-1 receptor agonists/antagonists, pasireotide, and stable glucagon under evaluation.

Somatostatin analogues: most effective
Peptide-based somatostatin analogues remain the gold standard for dumping syndrome, with pasireotide and GLP-1 drugs emerging as next-generation options

What the researchers found

Stepwise management: diet → acarbose/viscosity → somatostatin analogues (most effective). Refractory: diazoxide, SGLT2i. Emerging: pasireotide, GLP-1RA and GLP-1 antagonists, stable glucagon. Post-bariatric hypoglycemia is late dumping only.

Why it matters

Dumping syndrome is underdiagnosed after the surge in bariatric surgery. This review provides a clear management algorithm and highlights peptide-based therapies (somatostatin analogues, GLP-1 drugs) as central treatments.

How the study worked

Narrative review of dumping syndrome pathophysiology, diagnosis, and current/emerging treatments.

What this study cannot tell us

Many emerging therapies lack robust evidence. Somatostatin analogues are expensive. Surgical reintervention evidence is limited. "Post-bariatric hypoglycemia" may be overused for what is actually dumping syndrome.

How to read the evidence

Narrative review synthesizing current evidence and emerging therapies.

When this study was published

Published in 2025.

The bigger picture

Multiple peptide hormones are involved in dumping syndrome pathophysiology, and peptide-based treatments are correspondingly the most effective interventions—from somatostatin analogues to emerging GLP-1 and glucagon therapies.

Questions still open

Will pasireotide replace octreotide/lanreotide for dumping?
How do GLP-1 agonists and antagonists both help different aspects of dumping?
Should bariatric surgery patients be routinely screened for dumping?

Common questions

What is dumping syndrome?

A group of GI symptoms that occur after stomach surgery (especially bariatric surgery). "Early dumping" (nausea, bloating, diarrhea within 30 min of eating) and "late dumping" (weakness, sweating, dizziness 1-3 hours later from low blood sugar) are caused by food moving too quickly into the small intestine.

How is dumping syndrome treated?

Treatment starts with dietary changes (smaller meals, avoiding sugars, increasing fiber). If that is not enough, medications are added: acarbose (slows sugar absorption) or somatostatin analogues (the most effective option, using peptide injections to slow gut hormone release). New peptide-based treatments are being studied.

Read the original research

Dumping syndrome: Update on pathophysiology, diagnosis, and management.

Neurogastroenterology and motility, 37(2), e14962

View on PubMed ↗Publisher’s paper ↗

Citation

Tack, Jan; Raymenants, Karlien; Van de Bruaene, Cedric; Scarpellini, Emidio. (2025). Dumping syndrome: Update on pathophysiology, diagnosis, and management.. Neurogastroenterology and motility, 37(2), e14962. https://doi.org/10.1111/nmo.14962